Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue 1, 2000, Pages 8-15

  Heuschkel, Robert B ^b   Menache, Caroline C ^a   Megerian, J Thomas ^a   Baird, Alison E ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Child; Crohn's disease; Enteral nutrition; Metaanalysis of publications; Steroids

Indexed keywords

CORTICOSTEROID;

ARTICLE; CHILD; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CROHN DISEASE; DRUG EFFICACY; ENTERIC FEEDING; GROWTH RETARDATION; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBERTY; REMISSION; RISK BENEFIT ANALYSIS;

ACUTE DISEASE; ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; HUMANS; MALE; REMISSION INDUCTION; RISK; TREATMENT OUTCOME;

EID: 0033934166     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200007000-00005     Document Type: Article

References (59)

1. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Metaanalysis of enteral nutrition as a primary treatment of active Crohn's, disease. Gastroenterology 1995;108:1056-67.
2. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 1995;19:356-64.
3. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: A meta-analysis. Scand J Gastroenterol 1996;31: 267-72.
4. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-6.
5. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998;114:902-11.
6. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol 1993;16:341-6.
7. Walker-Smith JA. Dietary treatment of active Crohn's disease: Dietary treatment is best for children (letter; comment). BMJ 1997; 314:1827.
8. Savage MO, Beattie RM, Camacho-Hubner C, Walker-Smith JA, Sanderson IR. Growth in Crohn's disease. Acta Paediatr Suppl 1999;88:89-92.
9. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis (see comments). Gastroenterology 1994;107:1031-9.
10. Walker-Smith JA. Management of growth failure in Crohn's disease. Arch Dis Child 1996;75:351-4.
11. Navarro J, Vargas J, Cezard JP, Charritat JL, Polonovski C. Prolonged constant rate elemental enteral nutrition in Crohn's disease. J Pediatr Gastroenterol Nutr 1982;1:541-6.
12. Morin CL, Roulet M, Roy CC, Weber A. Continuous elemental enteral alimentation in children with Crohn's disease and growth failure. Gastroenterology 1980;79:1205-10.
13. Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987;62:123-7.
14. Beattie RM, Bentsen BS, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998;14:345-50.
15. Griffiths AM. Inflammatory bowel disease. Nutrition 1998;14: 788-91.
16. Duerksen DR, Nehra V, Bistrian BR, Blackburn GL, Appropriate nutritional support in acute and complicated Crohn's disease. Nutrition 1998;14:462-5.
17. O'Sullivan MA, O'Morain CA. Nutritional therapy in Crohn's disease. Inflamm Bowel Dis 1998;4:45-53.
18. Murch SH, Walker-Smith JA. Nutrition in inflammatory bowel disease. Baillieres Clin Gastroenterol 1998;12:719-38.
19. Griffiths AM. Crohn's disease in adolescents. Baillieres Clin Gastroenterol 1998;12:115-32.
20. Walker-Smith JA, Murch SH. Diseases of the small intestine in childhood. 4th ed. Oxford, England: ISIS Medical Media, 1999.
21. Walker-Smith JA. Therapy of Crohn's disease in childhood. Baillieres Clin Gastroenterol 1997;11:593-610.
22. Beattie RM, Camacho-Hubner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol (Oxf) 1998;49:483-9.
23. Khoshoo V, Reifen R, Neuman MG, Griffiths A, Pencharz PB. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease (see comments). JPEN J Parenter Enteral Nutr 1996;20: 401-5.
24. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988;94:603-10.
25. Morin CL, Roulet M, Roy CC, Weber A, Lapointe N. Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. JPEN J Parenter Enteral Nutr 1982;6:194-9.
26. Ricour C, Duhamel JF, Nihoul-Fekete C. Continuous enteral feeding in children: Technique and indications in 170 cases from 1969 to 1975 (in French). Arch Fr Pediatr 1977;34:154-70.
27. Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn's disease: Effect of enteral nutrition and treatment with prednisolone. Gut 1997;41: 203-8.
28. Breese EJ, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 1995;9:547-52.
29. Stober B, Nutzenadel W, Ullrich F, Basic diet in Crohn's disease (in German). Monatsschr Kinderheilkd 1983;131:721-4.
30. Nicholls S, Domizio P, Williams CB, et al. Cyclosporin as initial treatment for Crohn's disease. Arch Dis Child 1994;71:243-7.
31. Papadopoulou A, Rawashdeh MO, Brown GA, McNeish AS, Booth IW. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr 1995;84:79-83.
32. Summers RW, Switz DM, Sessions JTJ, et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979;77:847-69.
33. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment. Gastroenterology 1984;86:249-66.
34. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Ins 1959;22: 719-48.
35. Breslow NE, Day NE. The design and analysis of cohort studies. In: Statistical methods in cancer research. Vol. 2: Lyon, France: IARC Science Publications 1987;1-406.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
37. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 1993;17:75-81.
38. Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994;19:175-80.
39. Seidman E, Lohoues MJ, Turgeon L, Bouthillier L, Morin CL. Elemental diet versus prednisone as initial therapy in Crohn's disease: Early and long term results (abstract). Gastroenterology 1991;100:250.
40. Seidman E, Griffiths A, Jones A, Issenman R. Semi-elemental diet vs prednisolone in pediatric Crohn's disease (abstract). Gastroenterology 1993;104:778.
41. Breese EJ, Michie CA, Nicholls SW, et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-66.
42. Chafai S, Martin D, Goulet O, Mougenot JF, Ricour C, Schmitz J. Semi-elemental diet and corticosteroids in the treatment of Crohn's disease in children (abstract). J Pediatr Gastroenterol Nutr 1995; 220:465.
43. Breese E, MacDonald TT. TNF alpha secreting cells in normal and diseased human intestine. Adv Exp Med Biol 1995;371B:821-4.
44. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
45. Lloyd-Still JD, Green OC. A clinical scoring system for chronic inflammatory bowel disease in children. Dig Dis Sci 1979;24: 620-4.
46. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
47. Best WR, Becktel JM, Singleton JW, Kern FJ. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
48. Malchow H, Steinhardt HJ, Lorenz-Meyer H, et al. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol 1990;25:235-44.
49. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994;8:609-15.
50. Fell JM, Hollis A, Paintin M, Arnaud-Battandier F, MacDonald TT, Walker-Smith JA. Normalisation of mucosal cytokine mRNA in association with clinical improvement in children with Crohn's disease treated with polymeric diet (abstract). J Pediatr Gastroenterol Nutr 1998;26:544.
51. Brain CE, Savage MO. Growth and puberty in chrome inflammatory bowel disease. Baillieres Clin Gastroenterol 1994;8:83-100.
52. Teahon K, Bjarnason I, Pearson M, Levi AJ. Ten years' experience with an elemental diet in the management of Crohn's disease. Gut 1990;31:1133-7.
53. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease: Results of the European Cooperative Crohn's Disease Study Part IV (see comments). Gastroenterology 1991;101:881-8
54. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983: Marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989; 30:618-22.
55. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273: 408-12.
56. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease: Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990;98:811-8
57. Leichtner AM, Jackson DW, Grand RJ. Crohn's disease and ulcerative colitis. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, eds. Pediatric gastrointestinal disease: Pathophysiology, diagnostic, management. St Louis, MO: Mosby, 1996:692-726.
58. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
59. Richards ME, Rickert RR, Nance FC. Crohn's disease-associated carcinoma: A poorly recognized complication of inflammatory bowel disease. Ann Surg 1989;209:764-73.